Patents by Inventor Susan LaGreca

Susan LaGreca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cycloalkylamino Acid Derivatives
    Publication number: 20100120794
    Abstract: The invention relates to compounds of formula I and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R1, R2, R3, R4, R5, R8, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: January 4, 2010
    Publication date: May 13, 2010
    Inventors: Samit Kumar Bhattacharya, Matthew Frank Brown, Peter Hans Dorff, Susan LaGreca
  • Substituted pyrrolo[2,3-d]pyrimidine derivatives useful in cancer treatment
    Patent number: 7595325
    Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug, solvate or hydrate thereof, wherein L, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating abnormal cell growth, such as cancer in a mammal by administering the compounds of formula 1.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: September 29, 2009
    Assignee: Pfizer Inc.
    Inventors: Matthew A. Marx, Jinshan Chen, Susan LaGreca
  • CYCLOALKYLAMINO ACID DERIVATIVES
    Publication number: 20070270438
    Abstract: The invention relates to compounds of formula I and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R1, R2, R3, R4, R5, R8, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: May 9, 2007
    Publication date: November 22, 2007
    Inventors: Samit Bhattacharya, Matthew Brown, Peter Dorff, Susan LaGreca, Robert Maguire
  • Pyrrolopyrimidine derivatives useful in cancer treatment
    Publication number: 20060035912
    Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug, solvate or hydrate thereof, wherein L, R1, R2 R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating abnormal cell growth, such as cancer in a mammal by administering the compounds of formula 1.
    Type: Application
    Filed: May 27, 2005
    Publication date: February 16, 2006
    Inventors: Matthew Marx, Jinshan Chen, Susan Lagreca
  • Pyrrolopyre compounds useful in treatment of cancer
    Publication number: 20050130994
    Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein X, L, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.
    Type: Application
    Filed: November 16, 2004
    Publication date: June 16, 2005
    Inventors: Jinshan Chen, Matthew Marx, Susan LaGreca, Matthew Wessel